Stock Groups

Becton confident its COVID-19 tests will detect Omicron variant -Breaking

by Mike Robinson

[ad_1]


(Reuters) -Becton Dickinson and Co stated Tuesday that it is confident its COVID-19 test will be able detect Omicron, a new variant of coronavirus.

It sells several COVID-19 tests, including antigen as well as PCR. It began shipping home rapid COVID-19 testing in October. The tests can be confirmed using an automated smartphone app.

Becton also said it had conducted analyses of the variant using all available genome sequences from the Global Initiative on Sharing All Influenza Data (GISAID) — the largest database of novel coronavirus genome sequences in the world.

It added that millions of genomes had been analyzed and none undetectable variants were found.

The company’s announcement follows Thermo Fisher Scientific Inc (NYSE 🙂 confirming that it can detect Omicron variants with its diagnostic tests.

According to the World Health Organisation (WHO), Omicron was last week designated a SARS CoV-2 “variant concern” and warned that it might spread quicker than other forms.

Disclaimer: Fusion MediaWe remind you that this site does not contain accurate or real-time data. CFDs include stocks, indexes and futures. Prices are provided not by the exchanges. Market makers provide them. Therefore, prices can be inaccurate and differ from actual market prices. These prices should not be used for trading. Fusion Media is not responsible for trading losses that may be incurred as a consequence of the use of this data.

Fusion MediaFusion Media or any other person involved in the website will not be held responsible for any loss or damage resulting from reliance on this information, including charts, buy/sell signals, and data. You should be aware of all the potential risks and expenses associated with trading in the financial market. It is among the most dangerous investment types.

[ad_2]